HTG Molecular Diagnostics, Inc. (HTGMQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 4.83 Million USD | -58.72% |
| 2021 | 11.7 Million USD | -7.39% |
| 2020 | 12.64 Million USD | 12.35% |
| 2019 | 11.25 Million USD | 16.28% |
| 2018 | 9.67 Million USD | 10.56% |
| 2017 | 8.75 Million USD | -25.68% |
| 2016 | 11.77 Million USD | 8.57% |
| 2015 | 10.84 Million USD | -3.56% |
| 2014 | 11.24 Million USD | 25398.44% |
| 2013 | 44.12 Thousand USD | -78.5% |
| 2012 | 205.2 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | 3.98 Million USD | -17.65% |
| 2023 Q2 | - USD | -100.0% |
| 2022 Q1 | 9.46 Million USD | -19.13% |
| 2022 FY | 4.83 Million USD | -58.72% |
| 2022 Q2 | 9.06 Million USD | -4.24% |
| 2022 Q4 | 4.83 Million USD | -20.14% |
| 2022 Q3 | 6.05 Million USD | -33.25% |
| 2021 Q2 | 10.89 Million USD | -8.81% |
| 2021 Q1 | 11.94 Million USD | -5.55% |
| 2021 FY | 11.7 Million USD | -7.39% |
| 2021 Q3 | 11.94 Million USD | 9.72% |
| 2021 Q4 | 11.7 Million USD | -2.0% |
| 2020 Q4 | 12.64 Million USD | 0.61% |
| 2020 Q2 | 12.91 Million USD | 15.88% |
| 2020 Q1 | 11.14 Million USD | -0.96% |
| 2020 FY | 12.64 Million USD | 12.35% |
| 2020 Q3 | 12.56 Million USD | -2.7% |
| 2019 Q1 | 10.63 Million USD | 9.9% |
| 2019 Q4 | 11.25 Million USD | -1.27% |
| 2019 Q2 | 11.41 Million USD | 7.34% |
| 2019 FY | 11.25 Million USD | 16.28% |
| 2019 Q3 | 11.39 Million USD | -0.16% |
| 2018 Q1 | 9.54 Million USD | 9.09% |
| 2018 FY | 9.67 Million USD | 10.56% |
| 2018 Q3 | 9.63 Million USD | 0.45% |
| 2018 Q4 | 9.67 Million USD | 0.43% |
| 2018 Q2 | 9.59 Million USD | 0.47% |
| 2017 Q1 | 10.35 Million USD | -12.09% |
| 2017 FY | 8.75 Million USD | -25.68% |
| 2017 Q4 | 8.75 Million USD | 18.89% |
| 2017 Q3 | 7.36 Million USD | -17.11% |
| 2017 Q2 | 8.88 Million USD | -14.21% |
| 2016 Q1 | 15.77 Million USD | 45.42% |
| 2016 Q2 | 14.49 Million USD | -8.15% |
| 2016 Q3 | 13.15 Million USD | -9.2% |
| 2016 Q4 | 11.77 Million USD | -10.47% |
| 2016 FY | 11.77 Million USD | 8.57% |
| 2015 FY | 10.84 Million USD | -3.56% |
| 2015 Q1 | 13.94 Million USD | 24.0% |
| 2015 Q4 | 10.84 Million USD | 0.86% |
| 2015 Q3 | 10.75 Million USD | 0.83% |
| 2015 Q2 | 10.66 Million USD | -23.53% |
| 2014 Q4 | 11.24 Million USD | 4.2% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q2 | 10.31 Million USD | 0.0% |
| 2014 Q3 | 10.79 Million USD | 4.65% |
| 2014 FY | 11.24 Million USD | 25398.44% |
| 2013 Q4 | 44.12 Thousand USD | 0.0% |
| 2013 FY | 44.12 Thousand USD | -78.5% |
| 2012 FY | 205.2 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -115.801% |
| Arrayit Corporation | 1.07 Million USD | -348.349% |
| Atlantic International Corp. | 2.93 Million USD | -64.954% |
| Biocept, Inc. | 12.1 Million USD | 60.08% |
| Bioqual, Inc. | 3.58 Million USD | -34.764% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -6557.047% |
| DermTech, Inc. | 54.39 Million USD | 91.113% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 98.976% |
| iMD Companies, Inc. | 1.12 Million USD | -331.545% |
| IDenta Corp. | 789.14 Thousand USD | -512.554% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 56.809% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -10925.084% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 39.913% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -26.348% |
| NovelStem International Corp. | 3.57 Million USD | -35.23% |
| Optigenex Inc. | 8.94 Million USD | 45.933% |
| PharmChem, Inc. | 77.35 Thousand USD | -6149.206% |
| Proteome Sciences plc | 17.15 Million USD | 71.82% |
| Response Genetics, Inc | 6.37 Million USD | 24.15% |
| Rennova Health, Inc. | 15.32 Million USD | 68.466% |
| RushNet, Inc. | 4.82 Million USD | -0.225% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -2234.857% |
| Stella Diagnostics Inc. | 6.2 Million USD | 22.042% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -168.54% |
| Todos Medical Ltd. | 38.34 Million USD | 87.395% |